; (B) comprehensive, research-based, short- and long-term, quantifiable goals for addressing the emerging drug threat, including for reducing the supply of the drug designated as the emerging drug threat and for expanding the availability and effectiveness of evidence-based substance use disorder treatment and prevention programs to reduce the demand for the emerging drug threat; (C) performance measures pertaining to the plan’s goals, including quantifiable and measurable objectives and specific targets; (D) the level of funding needed to implement the plan, including whether funding is available to be reprogrammed or transferred to support implementation of the plan or whether additional appropriations are necessary to implement the plan; (E) an implementation strategy for the media campaign under subsection (f), including goals as described under subparagraph (B) of this paragraph and performance measures, objectives, and targets, as described under subparagraph (C) of this paragraph; and (F) any other information necessary to inform the public of the status, progress, or response of an emerging drug threat. (4) Implementation (A) In general Not later than 120 days after the date on which a designation is made under subsection (c), the Director, in consultation with the President, the appropriate congressional committees, and the head of each National Drug Control Program Agency, shall issue guidance on implementation of the plan described in this subsection to the National Drug Control Program Agencies and any other relevant agency determined to be necessary by the Director. (B) Coordinator’s responsibilities The Coordinator shall— (i) direct the implementation of the plan among the agencies identified in the plan, State, local, and Tribal governments, and other relevant entities; (ii) facilitate information-sharing between agencies identified in the plan, State, local, and Tribal governments, and other relevant entities